Lv2
160 积分 2024-06-25 加入
Eleven clinical trials that will shape medicine in 2026
2个月前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
2个月前
已完结
Antibody-Drug Conjugates in Combination Therapy: Defining the Next Chapter
2个月前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
3个月前
已完结
Treatment of NSCLC after chemoimmunotherapy — are we making headway?
4个月前
已完结
Synthetic lethal strategies for the development of cancer therapeutics
4个月前
已完结
Synthetic lethality in cancer drug discovery: challenges and opportunities
4个月前
已完结
The non-small-cell lung cancer drug market
4个月前
已关闭
Efficacy and Safety of Sunvozertinib Monotherapy as First-line Treatment in NSCLC Patients with EGFR Exon 20 Insertion Mutations: A Phase 2, Single-center Trial
5个月前
已完结
Sunvozertinib for patients in China with platinum-pretreated locally advanced or metastatic non-small-cell lung cancer and EGFR exon 20 insertion mutation (WU-KONG6): single-arm, open-label, multicentre, phase 2 trial
5个月前
已完结
皖公网安备34019202002308
